Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 30, 2018 Filed Nov 30, 2018 23:34 UTC |
Ketchum Steven BChief Scientific Officer
|
SaleOrdinary Shares | 17,042 | $17.79 | $303,173.77 |
DisclosureSEC source: 0001209191-18-060458 · doc4.xml · nonDerivative · entry 6 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 341,297 F1 · security: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.12 to $18.04, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F3 · ownership.direct: Please see the section titled "Remarks" below for additional information. Read SEC document |
| November 30, 2018 Filed Nov 30, 2018 23:34 UTC |
Ketchum Steven BChief Scientific Officer
|
Exercise / conversionOrdinary Shares | 2,771 | $2.95 | $8,174.45 |
DisclosureSEC source: 0001209191-18-060458 · doc4.xml · nonDerivative · entry 5 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 358,339 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F3 · ownership.direct: Please see the section titled "Remarks" below for additional information. Read SEC document |
| November 30, 2018 Filed Nov 30, 2018 23:34 UTC |
Ketchum Steven BChief Scientific Officer
|
Exercise / conversionOrdinary Shares | 3,750 | $2.50 | $9,375.00 |
DisclosureSEC source: 0001209191-18-060458 · doc4.xml · nonDerivative · entry 4 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 355,568 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F3 · ownership.direct: Please see the section titled "Remarks" below for additional information. Read SEC document |
| November 30, 2018 Filed Nov 30, 2018 23:34 UTC |
Ketchum Steven BChief Scientific Officer
|
Exercise / conversionOrdinary Shares | 3,750 | $2.50 | $9,375.00 |
DisclosureSEC source: 0001209191-18-060458 · doc4.xml · nonDerivative · entry 3 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 351,818 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F3 · ownership.direct: Please see the section titled "Remarks" below for additional information. Read SEC document |
| November 30, 2018 Filed Nov 30, 2018 23:34 UTC |
Ketchum Steven BChief Scientific Officer
|
Exercise / conversionOrdinary Shares | 4,167 | $2.50 | $10,417.50 |
DisclosureSEC source: 0001209191-18-060458 · doc4.xml · nonDerivative · entry 2 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 348,068 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F3 · ownership.direct: Please see the section titled "Remarks" below for additional information. Read SEC document |
| November 30, 2018 Filed Nov 30, 2018 23:34 UTC |
Ketchum Steven BChief Scientific Officer
|
Exercise / conversionOrdinary Shares | 2,604 | $1.40 | $3,645.60 |
DisclosureSEC source: 0001209191-18-060458 · doc4.xml · nonDerivative · entry 1 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 343,901 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F3 · ownership.direct: Please see the section titled "Remarks" below for additional information. Read SEC document |
| November 30, 2018 Filed Nov 30, 2018 23:33 UTC |
Kennedy Joseph TGeneral Counsel
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 18,749 | $0.00 Strike: $2.50 | $0.00 |
DisclosureSEC source: 0001209191-18-060457 · doc4.xml · derivative · entry 7 Kennedy Joseph T · CIK 0001408920 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,261 Underlying: Ordinary Shares · 18,749 shares Expires 2025-07-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: On July 6, 2015, the Reporting Person was granted an option to purchase 900,000 Ordinary Shares under the Plan. The shares subject to this option shall vest and become exercisable in 48 equal monthly installments on the last day of each month that began on July 31, 2015. F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| November 30, 2018 Filed Nov 30, 2018 23:33 UTC |
Kennedy Joseph TGeneral Counsel
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,604 | $0.00 Strike: $1.40 | $0.00 |
DisclosureSEC source: 0001209191-18-060457 · doc4.xml · derivative · entry 6 Kennedy Joseph T · CIK 0001408920 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,458 Underlying: Ordinary Shares · 2,604 shares Expires 2026-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: On February 1, 2016, the Reporting Person was granted an option to purchase 125,000 Ordinary Shares under the Plan. The shares subject to this option shall vest and become exercisable in 48 equal monthly installments on the last day of each month that began on February 29, 2016. F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| November 30, 2018 Filed Nov 30, 2018 23:33 UTC |
Kennedy Joseph TGeneral Counsel
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,953 | $0.00 Strike: $1.02 | $0.00 |
DisclosureSEC source: 0001209191-18-060457 · doc4.xml · derivative · entry 5 Kennedy Joseph T · CIK 0001408920 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,906 Underlying: Ordinary Shares · 1,953 shares Expires 2025-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: On February 2, 2015, the Reporting Person was granted an option to purchase 93,750 Ordinary Shares under the Amarin Corporation plc 2011 Stock Incentive Plan (the "Plan"). The shares subject to this option shall vest and become exercisable in 48 equal monthly installments on the last day of each month that began on February 28, 2015. F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| November 30, 2018 Filed Nov 30, 2018 23:33 UTC |
Kennedy Joseph TGeneral Counsel
|
SaleOrdinary Shares | 23,306 | $17.81 | $414,998.29 |
DisclosureSEC source: 0001209191-18-060457 · doc4.xml · nonDerivative · entry 4 Kennedy Joseph T · CIK 0001408920 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 217,934 F1 · security: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.24 to $18.05 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F3 · ownership.direct: Please see the section titled "Remarks" below for additional information. Read SEC document |
| November 30, 2018 Filed Nov 30, 2018 23:33 UTC |
Kennedy Joseph TGeneral Counsel
|
Exercise / conversionOrdinary Shares | 18,749 | $2.50 | $46,872.50 |
DisclosureSEC source: 0001209191-18-060457 · doc4.xml · nonDerivative · entry 3 Kennedy Joseph T · CIK 0001408920 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 241,240 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F3 · ownership.direct: Please see the section titled "Remarks" below for additional information. Read SEC document |
| November 30, 2018 Filed Nov 30, 2018 23:33 UTC |
Kennedy Joseph TGeneral Counsel
|
Exercise / conversionOrdinary Shares | 2,604 | $1.40 | $3,645.60 |
DisclosureSEC source: 0001209191-18-060457 · doc4.xml · nonDerivative · entry 2 Kennedy Joseph T · CIK 0001408920 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 222,491 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F3 · ownership.direct: Please see the section titled "Remarks" below for additional information. Read SEC document |
| November 30, 2018 Filed Nov 30, 2018 23:33 UTC |
Kennedy Joseph TGeneral Counsel
|
Exercise / conversionOrdinary Shares | 1,953 | $1.02 | $1,992.06 |
DisclosureSEC source: 0001209191-18-060457 · doc4.xml · nonDerivative · entry 1 Kennedy Joseph T · CIK 0001408920 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 219,887 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F3 · ownership.direct: Please see the section titled "Remarks" below for additional information. Read SEC document |
| November 12, 2018 Filed Nov 14, 2018 23:02 UTC |
THERO JOHN FDirector · President and CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 407,611 | $0.00 Strike: $1.35 | $0.00 |
DisclosureSEC source: 0001209191-18-058601 · doc4.xml · derivative · entry 6 THERO JOHN F · CIK 0001199637 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 407,611 shares Expires 2019-12-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: On December 21, 2009, the Reporting Person was granted an option to purchase 900,000 Ordinary Shares under the Amarin Corporation plc 2002 Stock Option Plan. The stock option is fully vested. F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| November 12, 2018 Filed Nov 14, 2018 23:02 UTC |
THERO JOHN FDirector · President and CEO
|
SaleOrdinary Shares | 5,000 | $20.72 | $103,610.00 |
DisclosureSEC source: 0001209191-18-058601 · doc4.xml · nonDerivative · entry 5 THERO JOHN F · CIK 0001199637 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,094,528 F1 · security: The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person established in 2017. The option reported in this Form 4 was granted in 2009 and was set to expire in 2019. F2 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.46 to $20.98, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff at the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F3 · balance_after: Please see the section titled "Remarks" below for additional information. Read SEC document |
| November 12, 2018 Filed Nov 14, 2018 23:02 UTC |
THERO JOHN FDirector · President and CEO
|
SaleOrdinary Shares | 222,158 | $19.71 | $4,378,645.32 |
DisclosureSEC source: 0001209191-18-058601 · doc4.xml · nonDerivative · entry 4 THERO JOHN F · CIK 0001199637 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,099,528 F1 · security: The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person established in 2017. The option reported in this Form 4 was granted in 2009 and was set to expire in 2019. F2 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.43 to $20.41, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff at the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F3 · balance_after: Please see the section titled "Remarks" below for additional information. Read SEC document |
| November 12, 2018 Filed Nov 14, 2018 23:02 UTC |
THERO JOHN FDirector · President and CEO
|
SaleOrdinary Shares | 244,031 | $19.03 | $4,643,251.05 |
DisclosureSEC source: 0001209191-18-058601 · doc4.xml · nonDerivative · entry 3 THERO JOHN F · CIK 0001199637 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,321,686 F1 · security: The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person established in 2017. The option reported in this Form 4 was granted in 2009 and was set to expire in 2019. F2 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.43 to $19.42, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff at the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F3 · balance_after: Please see the section titled "Remarks" below for additional information. Read SEC document |
| November 12, 2018 Filed Nov 14, 2018 23:02 UTC |
THERO JOHN FDirector · President and CEO
|
SaleOrdinary Shares | 136,422 | $18.05 | $2,462,389.82 |
DisclosureSEC source: 0001209191-18-058601 · doc4.xml · nonDerivative · entry 2 THERO JOHN F · CIK 0001199637 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,565,717 F1 · security: The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person established in 2017. The option reported in this Form 4 was granted in 2009 and was set to expire in 2019. F2 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.43 to $18.42, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff at the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F3 · balance_after: Please see the section titled "Remarks" below for additional information. Read SEC document |
| November 12, 2018 Filed Nov 14, 2018 23:02 UTC |
THERO JOHN FDirector · President and CEO
|
Exercise / conversionOrdinary Shares | 407,611 | $1.35 | $550,274.85 |
DisclosureSEC source: 0001209191-18-058601 · doc4.xml · nonDerivative · entry 1 THERO JOHN F · CIK 0001199637 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,702,139 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person established in 2017. The option reported in this Form 4 was granted in 2009 and was set to expire in 2019. F2 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F3 · balance_after: Please see the section titled "Remarks" below for additional information. Read SEC document |
| October 31, 2018 Filed Nov 2, 2018 22:11 UTC |
Ketchum Steven BChief Scientific Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,771 | $0.00 Strike: $2.95 | $0.00 |
DisclosureSEC source: 0001209191-18-057000 · doc4.xml · derivative · entry 12 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,311 Underlying: Ordinary Shares · 2,771 shares Expires 2027-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_date: On February 1, 2017, the Reporting Person was granted an option to purchase 133,000 Ordinary Shares under the Plan. The shares subject to this option shall vest and become exercisable in 48 equal monthly installments on the last day of each month that began on February 28, 2017. F1 · derivative.underlying: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. Read SEC document |
| October 31, 2018 Filed Nov 2, 2018 22:11 UTC |
Ketchum Steven BChief Scientific Officer
|
Exercise / conversionStock Option · Derivative | 3,750 | $0.00 Strike: $2.50 | $0.00 |
DisclosureSEC source: 0001209191-18-057000 · doc4.xml · derivative · entry 11 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,438 Underlying: Ordinary Shares · 3,750 shares Expires 2025-07-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: On July 6, 2015, the Reporting Person was granted an option to purchase 180,000 Ordinary Shares under the Plan. The vesting of the shares is subject to certain performance milestone that was previously achieved. The shares subject to this option shall vest and become exercisable in 48 equal monthly installments on the last day of each month that began on July 31, 2015. F1 · derivative.underlying: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. Read SEC document |
| October 31, 2018 Filed Nov 2, 2018 22:11 UTC |
Ketchum Steven BChief Scientific Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,750 | $0.00 Strike: $2.50 | $0.00 |
DisclosureSEC source: 0001209191-18-057000 · doc4.xml · derivative · entry 10 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Ordinary Shares · 3,750 shares Expires 2025-07-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: On July 6, 2015, the Reporting Person was granted an option to purchase 180,000 Ordinary Shares under the Plan. The vesting of the shares is subject to certain performance milestone that was previously achieved. The shares subject to this option shall vest and become exercisable in 48 equal monthly installments on the last day of each month that began on July 31, 2015. F1 · derivative.underlying: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. Read SEC document |
| October 31, 2018 Filed Nov 2, 2018 22:11 UTC |
Ketchum Steven BChief Scientific Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 4,167 | $0.00 Strike: $2.50 | $0.00 |
DisclosureSEC source: 0001209191-18-057000 · doc4.xml · derivative · entry 9 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,332 Underlying: Ordinary Shares · 4,167 shares Expires 2025-07-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: On July 6, 2015, the Reporting Person was granted an option to purchase 200,000 Ordinary Shares under the Plan. The shares subject to this option shall vest and become exercisable in 48 equal monthly installments on the last day of each month that began on July 31, 2015. F1 · derivative.underlying: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. Read SEC document |
| October 31, 2018 Filed Nov 2, 2018 22:11 UTC |
Ketchum Steven BChief Scientific Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,604 | $0.00 Strike: $1.40 | $0.00 |
DisclosureSEC source: 0001209191-18-057000 · doc4.xml · derivative · entry 8 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,062 Underlying: Ordinary Shares · 2,604 shares Expires 2026-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: On February 1, 2016, the Reporting Person was granted an option to purchase 125,000 Ordinary Shares under the Amarin Corporation plc 2011 Stock Incentive Plan (the "Plan"). The shares subject to this option shall vest and become exercisable in 48 equal monthly installments on the last day of each month that began on February 29, 2016. F1 · derivative.underlying: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. Read SEC document |
| October 31, 2018 Filed Nov 2, 2018 22:11 UTC |
Ketchum Steven BChief Scientific Officer
|
SaleOrdinary Shares | 500 | $21.39 | $10,697.00 |
DisclosureSEC source: 0001209191-18-057000 · doc4.xml · nonDerivative · entry 7 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 341,297 F1 · security: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.33 to $21.53, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F3 · ownership.direct: Please see the section titled "Remarks" below for additional information. Read SEC document |
| October 31, 2018 Filed Nov 2, 2018 22:11 UTC |
Ketchum Steven BChief Scientific Officer
|
SaleOrdinary Shares | 16,542 | $20.72 | $342,756.86 |
DisclosureSEC source: 0001209191-18-057000 · doc4.xml · nonDerivative · entry 6 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 341,797 F1 · security: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.32 to $21.31, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F3 · ownership.direct: Please see the section titled "Remarks" below for additional information. Read SEC document |
| October 31, 2018 Filed Nov 2, 2018 22:11 UTC |
Ketchum Steven BChief Scientific Officer
|
Exercise / conversionOrdinary Shares | 2,771 | $2.95 | $8,174.45 |
DisclosureSEC source: 0001209191-18-057000 · doc4.xml · nonDerivative · entry 5 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 358,339 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F3 · ownership.direct: Please see the section titled "Remarks" below for additional information. Read SEC document |
| October 31, 2018 Filed Nov 2, 2018 22:11 UTC |
Ketchum Steven BChief Scientific Officer
|
Exercise / conversionOrdinary Shares | 3,750 | $2.50 | $9,375.00 |
DisclosureSEC source: 0001209191-18-057000 · doc4.xml · nonDerivative · entry 4 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 355,568 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F3 · ownership.direct: Please see the section titled "Remarks" below for additional information. Read SEC document |
| October 31, 2018 Filed Nov 2, 2018 22:11 UTC |
Ketchum Steven BChief Scientific Officer
|
Exercise / conversionOrdinary Shares | 3,750 | $2.50 | $9,375.00 |
DisclosureSEC source: 0001209191-18-057000 · doc4.xml · nonDerivative · entry 3 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 351,818 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F3 · ownership.direct: Please see the section titled "Remarks" below for additional information. Read SEC document |
| October 31, 2018 Filed Nov 2, 2018 22:11 UTC |
Ketchum Steven BChief Scientific Officer
|
Exercise / conversionOrdinary Shares | 4,167 | $2.50 | $10,417.50 |
DisclosureSEC source: 0001209191-18-057000 · doc4.xml · nonDerivative · entry 2 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 348,068 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F3 · ownership.direct: Please see the section titled "Remarks" below for additional information. Read SEC document |
| October 31, 2018 Filed Nov 2, 2018 22:11 UTC |
Ketchum Steven BChief Scientific Officer
|
Exercise / conversionOrdinary Shares | 2,604 | $1.40 | $3,645.60 |
DisclosureSEC source: 0001209191-18-057000 · doc4.xml · nonDerivative · entry 1 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 343,901 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F3 · ownership.direct: Please see the section titled "Remarks" below for additional information. Read SEC document |
| October 31, 2018 Filed Nov 2, 2018 22:10 UTC |
Kennedy Joseph TGeneral Counsel
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 18,750 | $0.00 Strike: $2.50 | $0.00 |
DisclosureSEC source: 0001209191-18-056999 · doc4.xml · derivative · entry 8 Kennedy Joseph T · CIK 0001408920 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,010 Underlying: Ordinary Shares · 18,750 shares Expires 2025-07-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: On July 6, 2015, the Reporting Person was granted an option to purchase 900,000 Ordinary Shares under the Plan. The shares subject to this option shall vest and become exercisable in 48 equal monthly installments on the last day of each month that began on July 31, 2015. F1 · derivative.underlying: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. Read SEC document |
| October 31, 2018 Filed Nov 2, 2018 22:10 UTC |
Kennedy Joseph TGeneral Counsel
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,604 | $0.00 Strike: $1.40 | $0.00 |
DisclosureSEC source: 0001209191-18-056999 · doc4.xml · derivative · entry 7 Kennedy Joseph T · CIK 0001408920 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,062 Underlying: Ordinary Shares · 2,604 shares Expires 2026-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: On February 1, 2016, the Reporting Person was granted an option to purchase 125,000 Ordinary Shares under the Plan. The shares subject to this option shall vest and become exercisable in 48 equal monthly installments on the last day of each month that began on February 29, 2016. F1 · derivative.underlying: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. Read SEC document |
| October 31, 2018 Filed Nov 2, 2018 22:10 UTC |
Kennedy Joseph TGeneral Counsel
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,953 | $0.00 Strike: $1.02 | $0.00 |
DisclosureSEC source: 0001209191-18-056999 · doc4.xml · derivative · entry 6 Kennedy Joseph T · CIK 0001408920 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,859 Underlying: Ordinary Shares · 1,953 shares Expires 2025-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: On February 2, 2015, the Reporting Person was granted an option to purchase 93,750 Ordinary Shares under the Amarin Corporation plc 2011 Stock Incentive Plan (the "Plan"). The shares subject to this option shall vest and become exercisable in 48 equal monthly installments on the last day of each month that began on February 28, 2015. F1 · derivative.underlying: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. Read SEC document |
| October 31, 2018 Filed Nov 2, 2018 22:10 UTC |
Kennedy Joseph TGeneral Counsel
|
SaleOrdinary Shares | 600 | $21.37 | $12,820.98 |
DisclosureSEC source: 0001209191-18-056999 · doc4.xml · nonDerivative · entry 5 Kennedy Joseph T · CIK 0001408920 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 217,934 F1 · security: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.32 to $21.45, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F3 · ownership.direct: Please see the section titled "Remarks" below for additional information. Read SEC document |
| October 31, 2018 Filed Nov 2, 2018 22:10 UTC |
Kennedy Joseph TGeneral Counsel
|
SaleOrdinary Shares | 22,707 | $20.72 | $470,541.27 |
DisclosureSEC source: 0001209191-18-056999 · doc4.xml · nonDerivative · entry 4 Kennedy Joseph T · CIK 0001408920 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 218,534 F1 · security: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.32 to $21.28 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F3 · ownership.direct: Please see the section titled "Remarks" below for additional information. Read SEC document |
| October 31, 2018 Filed Nov 2, 2018 22:10 UTC |
Kennedy Joseph TGeneral Counsel
|
Exercise / conversionOrdinary Shares | 18,750 | $2.50 | $46,875.00 |
DisclosureSEC source: 0001209191-18-056999 · doc4.xml · nonDerivative · entry 3 Kennedy Joseph T · CIK 0001408920 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 241,241 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F3 · ownership.direct: Please see the section titled "Remarks" below for additional information. Read SEC document |
| October 31, 2018 Filed Nov 2, 2018 22:10 UTC |
Kennedy Joseph TGeneral Counsel
|
Exercise / conversionOrdinary Shares | 2,604 | $1.40 | $3,645.60 |
DisclosureSEC source: 0001209191-18-056999 · doc4.xml · nonDerivative · entry 2 Kennedy Joseph T · CIK 0001408920 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 222,491 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F3 · ownership.direct: Please see the section titled "Remarks" below for additional information. Read SEC document |
| October 31, 2018 Filed Nov 2, 2018 22:10 UTC |
Kennedy Joseph TGeneral Counsel
|
Exercise / conversionOrdinary Shares | 1,953 | $1.02 | $1,992.06 |
DisclosureSEC source: 0001209191-18-056999 · doc4.xml · nonDerivative · entry 1 Kennedy Joseph T · CIK 0001408920 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 219,887 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F3 · ownership.direct: Please see the section titled "Remarks" below for additional information. Read SEC document |
| October 01, 2018 Filed Oct 2, 2018 23:02 UTC |
Kennedy Joseph TGeneral Counsel
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,604 | $0.00 Strike: $1.40 | $0.00 |
DisclosureSEC source: 0001209191-18-053462 · doc4.xml · derivative · entry 14 Kennedy Joseph T · CIK 0001408920 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,666 Underlying: Ordinary Shares · 2,604 shares Expires 2026-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F14 · derivative.exercise_date: On February 1, 2016, the Reporting Person was granted an option to purchase 125,000 Ordinary Shares under the Plan. The shares subject to this option shall vest and become exercisable in 48 equal monthly installments on the last day of each month that began on February 29, 2016. F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| October 01, 2018 Filed Oct 2, 2018 23:02 UTC |
Kennedy Joseph TGeneral Counsel
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 18,749 | $0.00 Strike: $2.50 | $0.00 |
DisclosureSEC source: 0001209191-18-053462 · doc4.xml · derivative · entry 13 Kennedy Joseph T · CIK 0001408920 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 168,760 Underlying: Ordinary Shares · 18,749 shares Expires 2025-07-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F13 · derivative.exercise_date: On July 6, 2015, the Reporting Person was granted an option to purchase 900,000 Ordinary Shares under the Plan. The shares subject to this option shall vest and become exercisable in 48 equal monthly installments on the last day of each month that began on July 31, 2015. F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| October 01, 2018 Filed Oct 2, 2018 23:02 UTC |
Kennedy Joseph TGeneral Counsel
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,953 | $0.00 Strike: $1.02 | $0.00 |
DisclosureSEC source: 0001209191-18-053462 · doc4.xml · derivative · entry 12 Kennedy Joseph T · CIK 0001408920 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,812 Underlying: Ordinary Shares · 1,953 shares Expires 2025-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F12 · derivative.exercise_date: On February 2, 2015, the Reporting Person was granted an option to purchase 93,750 Ordinary Shares under the Plan. The shares subject to this option shall vest and become exercisable in 48 equal monthly installments on the last day of each month that began on February 28, 2015. F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| October 01, 2018 Filed Oct 2, 2018 23:02 UTC |
Kennedy Joseph TGeneral Counsel
|
SaleOrdinary Shares | 8,400 | $17.99 | $151,129.44 |
DisclosureSEC source: 0001209191-18-053462 · doc4.xml · nonDerivative · entry 9 Kennedy Joseph T · CIK 0001408920 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 217,934 F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F7 · security: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F10 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.80 to $18.45, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F4 · ownership.direct: Please see the section titled "Remarks" below for additional information. Read SEC document |
| October 01, 2018 Filed Oct 2, 2018 23:02 UTC |
Kennedy Joseph TGeneral Counsel
|
SaleOrdinary Shares | 8,800 | $17.47 | $153,695.52 |
DisclosureSEC source: 0001209191-18-053462 · doc4.xml · nonDerivative · entry 8 Kennedy Joseph T · CIK 0001408920 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 226,334 F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F7 · security: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.80 to $17.79, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F4 · ownership.direct: Please see the section titled "Remarks" below for additional information. Read SEC document |
| October 01, 2018 Filed Oct 2, 2018 23:02 UTC |
Kennedy Joseph TGeneral Counsel
|
SaleOrdinary Shares | 33,049 | $16.33 | $539,703.39 |
DisclosureSEC source: 0001209191-18-053462 · doc4.xml · nonDerivative · entry 7 Kennedy Joseph T · CIK 0001408920 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 235,134 F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F7 · security: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.80 to $16.78, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F4 · ownership.direct: Please see the section titled "Remarks" below for additional information. Read SEC document |
| October 01, 2018 Filed Oct 2, 2018 23:02 UTC |
Kennedy Joseph TGeneral Counsel
|
Exercise / conversionOrdinary Shares | 2,604 | $1.40 | $3,645.60 |
DisclosureSEC source: 0001209191-18-053462 · doc4.xml · nonDerivative · entry 6 Kennedy Joseph T · CIK 0001408920 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 268,183 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F7 · security: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F4 · ownership.direct: Please see the section titled "Remarks" below for additional information. Read SEC document |
| October 01, 2018 Filed Oct 2, 2018 23:02 UTC |
Kennedy Joseph TGeneral Counsel
|
Exercise / conversionOrdinary Shares | 18,749 | $2.50 | $46,872.50 |
DisclosureSEC source: 0001209191-18-053462 · doc4.xml · nonDerivative · entry 5 Kennedy Joseph T · CIK 0001408920 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 265,579 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F7 · security: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F4 · ownership.direct: Please see the section titled "Remarks" below for additional information. Read SEC document |
| October 01, 2018 Filed Oct 2, 2018 23:02 UTC |
Kennedy Joseph TGeneral Counsel
|
Exercise / conversionOrdinary Shares | 1,953 | $1.02 | $1,992.06 |
DisclosureSEC source: 0001209191-18-053462 · doc4.xml · nonDerivative · entry 4 Kennedy Joseph T · CIK 0001408920 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 246,830 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F7 · security: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F4 · ownership.direct: Please see the section titled "Remarks" below for additional information. Read SEC document |
| October 01, 2018 Filed Oct 2, 2018 23:05 UTC |
Ketchum Steven BChief Scientific Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,604 | $0.00 Strike: $1.40 | $0.00 |
DisclosureSEC source: 0001209191-18-053469 · doc4.xml · derivative · entry 17 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,666 Underlying: Ordinary Shares · 2,604 shares Expires 2026-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: On February 1, 2016, the Reporting Person was granted an option to purchase 125,000 Ordinary Shares under the Plan. The shares subject to this option shall vest and become exercisable in 48 equal monthly installments on the last day of each month that began on February 29, 2016. F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| October 01, 2018 Filed Oct 2, 2018 23:05 UTC |
Ketchum Steven BChief Scientific Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 4,167 | $0.00 Strike: $2.50 | $0.00 |
DisclosureSEC source: 0001209191-18-053469 · doc4.xml · derivative · entry 16 Ketchum Steven B · CIK 0001289884 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,499 Underlying: Ordinary Shares · 4,167 shares Expires 2025-07-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: On July 6, 2015, the Reporting Person was granted an option to purchase 200,000 Ordinary Shares under the Plan. The shares subject to this option shall vest and become exercisable in 48 equal monthly installments on the last day of each month that began on July 31, 2015. F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.